Lowest Price Guaranteed From USD 3,499
From my point of view, the prospects of spray drying for pharmaceutical products are promising. I believe that this technology may turn out to be a well-suited option for value added generics (or super generics); further, depending on the evolution of the aforementioned products, the growth may be impacted
-Director, Business Development, Spain based small-sized CMO
The pharmaceutical spray drying market is estimated to be worth $130 million in 2018 and is expected to grow at CAGR of 18% during the forecast period. The origins of spray drying can be traced back to 1872, when the first patent related to the technique was registered in the US. The first commercial use of this form of drying was reported in the 1920s when powdered milk was introduced into the market. Spray drying, which is already established in the food and chemical sector, is also considered to be a rapid, cost-effective, and scalable process for the production of dry powder formulations of pharmacological material. Owing to characteristics, such as reproducibility and its continuous mode of operation, the technique has become very popular in the pharmaceutical and biotechnology industry. It offers several advantages over alternate drying technologies, such as lyophilization (characterized by high dependence on cold chain for storage and logistics, which is prone to failure due to human error) and vacuum foam drying (characterized by volumetric restrictions due to the properties of foam, which limits the quantity of sample that can be dried in a single run) that are currently deployed in the pharmaceutical industry.
Amongst other merits, spray drying is known to be suitable for drying heat-sensitive products such as biologics. Moreover, this method imparts improved properties to the formulations that can be administered through more efficient and less invasive modes of delivery, such as oral, and inhalation routes. The technology also aids in improving the compression properties of drugs, allowing developers to design concentrated dose variants of medications and reduce tablet size. Such alterations have the potential to improve patient compliance. Given the flexibility offered in terms of drug development and formulation, the economics of the technique, the introduction of aseptic methods, and the recent approval of the first spray dried biologic, Raplixa ®, the adoption of spray drying is anticipated to increase steadily in the pharmaceutical industry.
Examples of key companies engaged in pharmaceutical spray drying market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Buchi Labortechnik, GEA Niro, Hemraj India, SPX (SPX FLOW), Techni Process, Labultima and Advanced Drying Systems. This market report includes an easily searchable excel database of all the companies providing pharmaceutical spray drying equipment and services, worldwide.
The ‘Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028’ market report provides an extensive study on the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities of the pharmaceutical spray drying market. The key focus of the market report is primarily to estimate the future potential of spray drying in the manufacturing of APIs, inhalables, injectables, biologics and other pharmaceutical products. The market report presents an in-depth analysis of a diverse set of companies that provide spray drying equipment and services across different regions of the globe.Amongst other elements, the market research report includes:
The key objective of pharmaceutical spray drying market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity for pharmaceutical spray drying market during the forecast period. Based on parameters, such as trends in the pharmaceutical contract manufacturing industry, operation costs associated with spray drying and the challenges and opportunities presented by this technique, we have provided an informed estimate of the likely evolution of the market in the long term, for the forecast period 2018-2028. In addition, we have provided insights on the likely regional evolution of the market in North America, Europe, Asia Pacific and the rest of the world. It also includes estimates regarding the likely distribution of the market based on type of industry (pharmaceuticals and biologics) and type of nozzles used in spray dryers (fluid nozzle, pressure nozzle, rotary disc atomizer, centrifugal nozzle, and others). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have presented three different market forecast scenarios, depicting conservative, base and optimistic tracks of the market’s evolution.
The research, analysis and insights presented in this market report is backed by a deep understanding of insights gathered both from secondary and primary sources. The opinions and insights presented in this market research report were influenced by discussions conducted with several key players in pharmaceutical spray drying market. The market report features detailed transcripts of interviews held with the following key opinion leaders:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.